Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T21:52:32.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, indicating restricted access or a server-side issue preventing viewing the trial details. This change affects the user experience by preventing access to the main content on the page.
    Difference
    0.5%
    Check dated 2026-09-26T21:38:23.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study record, indicating access to the NCT04907968 listing is blocked; the new screenshot displays the error message and site chrome instead of the study details.
    Difference
    19%
    Check dated 2026-09-19T20:54:51.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This indicates a minor update to the page’s content or formatting rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:38:57.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page renders an error page instead of the study details, indicating the study record is unavailable.
    Difference
    18%
    Check dated 2026-08-08T18:52:39.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.4) indicating a backend update; the core study information and presentation remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T10:27:03.000Z thumbnail image

Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.